Adrenocorticotropic hormone is produced in the ventricle of patients with essential hypertension

Journal of Hypertension

Volumn 23, Issue 2, 2005, Pages 411-416

  Mizuno, Yuji ^a   Yasue, Hirofumi ^a   Yoshimura, Michihiro ^b   Harada, Eisaku ^a   Fujii, Hiromi ^a   Nakamura, Shota ^b   Yamamoto, Nobuyasu ^a   Ogawa, Hisao ^b   Nakao, Kazuwa ^c  

^a Kumamoto Aging Research Institute   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Adrenocorticotropic hormone; Aldosterone; Cortisol; Essential hypertension

Indexed keywords

ALDOSTERONE; CORTICOTROPIN; HYDROCORTISONE; MINERALOCORTICOID;

ADRENAL CORTEX; ADULT; AGED; ALDOSTERONE RELEASE; AORTA ROOT; ARTICLE; BLOOD PRESSURE REGULATION; CORONARY SINUS; CORTICOTROPIN RELEASE; DRUG BLOOD LEVEL; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; HEART CATHETERIZATION; HEART VENTRICLE FUNCTION; HORMONAL REGULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL;

EID: 14044267576     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200502000-00024     Document Type: Article

References (37)

1. Laragh JH. Renin-angiotensin-aldosterone system for blood pressure and electrolyte homeostasis and its involvement in hypertension, in congestive heart failure and in associated cardiovascular damage. J Hum Hypertens 1995; 9:385-390.
2. Williams GH, Dluhy RG. Disorders of adrenal cortex. In: Braunwald E, Fauci AS, Kasper DL, Houser SL, Longo DL, Jameson JL (editors): Harrison's principles of internal medicine, 15th edition. New York: McGraw-Hill; 2001, pp. 2084-2105.
3. Silvestre JS, Robert V, Heymes C, Aupetit-Faisant B, Mouas C, Moalic JM, et al. Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation. J Biol Chem 1998; 273:4883-4891.
4. Hatakeyama H, Miyamori I, Fujita T, Takeda Y, Takeda R, Yamamoto H. Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem 1994; 269:24316-24320.
5. Gomez-Sanchez CE, Zhou MY, Cozza EN, Mrita H, Foecking MF, Gomez-Sanchez EP. Aldosterone biosynthesis in the rat brain. Endocrinology 1997; 138:3369-3373.
6. Slight SH, Joseph J, Ganjam VK, Weber KT. Extra-adrenal mineralocorticoids and cardiovascular tissue. J Mol Cell Cardiol 1999; 31:1175-1184.
7. Mizuno Y, Michihiro Y, Yasue H, Sakamoto T, Ogawa H, Kugiyama K, et al. Aldosterone production is activated in failing ventricle in humans. Circulation 2001; 103:72-77.
8. Yamamoto N, Yasue H, Mizuno Y, Yoshimura M, Fujii H, Nakayama M, et al. Aldosterone is produced from the ventricles of patients with essential hypertension. Hypertension 2002; 39:958-962.
9. Kayes-Wandover KM, White PC. Steroidogenic enzyme gene expression in the human heart. J Clin Endocrinol Metab 2000; 85:2519-2525.
10. Young MJ, Clyne CD, Cole TJ, Funder JW. Cardiac steroidogenesis in the normal and failing heart. J Clin Endocrinol Metab 2001; 86:5121-5126.
11. Yoshimura M, Nakamura S, Ito T, Nakayama M, Harada E, Mizuno Y, et al. Expression of aldosterone synthase gene in failing human heart: quantitative analysis using modified real-time polymerase chain reaction. J Clin Endocrinol Metab 2002; 87:3936-3940.
12. Roberts DL, Nakazawa HK, Klocke FJ. Origin of great cardiac vein and coronary sinus drainage within the left ventricle. Am J Physiol 1976; 230:486-492.
13. Yasue H, Obata K, Okumura K, Kurose M, Ogawa H, Matsuyama K, et al. Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy. J Clin Invest 1989; 83:46-51.
14. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. J Hypertens 1999; 17:151-183.
15. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90:195-203.
16. Ikeda I, Iinuma K, Takai M, Yanagawa Y, Kurata K, Ogihara T, et al. Measurement of plasma renin activity by a simple solid phase radioimmunoassay. J Clin Endocrinol Metab 1982; 54:423-428.
17. Ramschak-Schwarzer S, Lipp R, Passath A, Warnkross H, Stiegler-Heinz C, Dobnig H, et al. Clinical value of the various methods of ACTH determination. Acta Med Austriaca 1993; 20:81-84.
18. Sapin R, Schllenger JL, Gasser F, Pradignac A, Grucker D. Improved specificity of a new direct assay for urinary cortisol: application in corticoid treated patients. Clin Chem Lab Med 1998; 36:855-858.
19. Zar JH. Biostatistical analysis, 2nd edition. Upper Saddle River, NJ: Prentice-Hall; 1984, pp. 162-184.
20. Mizuno Y, Yasue H, Yoshimura M, Fujii H, Yamamoto N, Nakayama M, et al. Effects of perindopril on aldosterone production in the failing human heart. Am J Cardiol 2002; 89:1197-1200.
21. Tsutamoto T, Wada A, Maeda K, Hayashi M, Tsutsui T, Ohnishi M, et al. Transcardiac gradient of aldosterone before and after spironolactone in patients with congestive heart failure. J Cardiovasc Pharmacol 2003; 41:S19-S22.
22. Hayashi M, Tsutamoto T, Wada A, Maeda K, Mabuchi N, Tsutsui T, et al. Relationship between transcardiac extraction of aldosterone, and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol 2001; 38:1375-1382.
23. Miller WL. Molecular biology of steroid hormone synthesis. Endocr Rev 1988; 9:295-318.
24. White PC. Aldosterone: direct effects on and production by the heart. J Clin Endocrinol Metab 2003; 88:2376-2383.
25. Young MJ, Funder JW. Mineralocorticoid receptors and pathophysiological roles for aldosterone in the cardiovascular system. J Hypertens 2002; 20:1465-1468.
26. Rajagopalan S, Pitt B. Aldosterone antagonists in the treatment of hypertension and target organ damage. Current Hypertens Rep 2001; 3:240-248.
27. Rocha R, Stier CT Jr. Pathophysiological effects of aldosterone in cardiovascular tissues. Trends Endocrinol Metab 2001; 12:308-314.
28. Walker BR, Campbell JC, Fraser R, Stewart PM, Edwards CR. Mineralocorticoid excess and inhibition of 11β-hydroxysteroid dehydrogenase in patients with ectopic ACTH syndrome. Clin Endocrinol 1992; 37:481-482.
29. Hatakeyama H, Inaba S, Taniguchi N, Miyamori I. Functional adrenocorticotropic hormone receptor in cultured human vascular endothelial cells. Possible role in control of blood pressure. Hypertension 2000; 36:862-865.
30. Saruta T. Mechanism of glucocorticoid-induced hypertension. Hypertens Res 1996; 19:1-8.
31. Young MJ, Moussa L, Dilley R, Funder JW. Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11β- hydroxysteroid dehydrogenase inactivation. Endocrinology 2003; 144:1121-1125.
32. Williams GH, Moore TJ, Hollenberg NK. Dysregulation of aldosterone secretion and its relationship to the pathogenesis of essential hypertension. Endocrinol Metab Clin North Am 1991; 20:423-447.
33. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension 1996; 27:481-490.
34. Millington WR, Rosenthal DW, Unal CB, Nyquist-Battie C. Localization of pro-opiomelanocortin mRNA transcripts and peptide immunoreactivity in rat heart. Cardiovasc Res 1999; 43:107-116.
35. Arzt E. gp130 cytokine signaling in the pituitary gland: a paradigm for cytokine-neuro-endocrine pathways. J Clin Invest 2001; 108:1729-1733.
36. Ishikawa M, Saito Y, Miyamoto Y, Harada M, Kuwahara K, Ogawa E, et al. A heart-specific increase in cardiotrophin-1 gene expression precedes the establishment of ventricular hypertrophy in genetically hypertensive rats. J Hypertens 1999; 17:807-816.
37. Hunter JJ, Chien KR. Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 1999; 341:1276-1283.